Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties

被引:0
作者
Torkashvand, Fatemeh [1 ]
Mehranfar, Mahsa [1 ]
Gero, Mahsa Rashidi [1 ,2 ]
Jafarian, Parisa [1 ,3 ]
Mirabzadeh, Esmat [1 ]
Azarian, Bahareh [1 ]
Sardari, Soroush [1 ]
Vaziri, Behrouz [1 ,4 ]
机构
[1] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran
[2] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[3] Islamic Azad Univ, Fac Biol Sci, Dept Biochem, North Tehra branch, Tehran, Iran
[4] Pasteur Inst Iran, Biotechnol Res Ctr, 69,Pasteur St, Tehran 1316943551, Iran
关键词
Monoclonal antibodies; Pharmacokinetics; Trastuzumab;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Post-translational modifications in bioprocessing and storage of recombinant mAbs are the main sources of charge variants. While the profile of these kinds of variants is considered an important quality attribute of therapeutic mAbs, there is controversy about their direct role on safety and efficacy. In this study, the physicochemical and PK properties of separated charge variants belonging to a trastuzumab potential biosimilar were examined.Methods: The APs, BPs, and main variants of trastuzumab were separated and enriched by semi-preparative WCX. A panel of analytical techniques was utilized to characterize the physicochemical properties of these variants. The binding affinity to HER2 and Fc & gamma;Rs and the PK parameters were evaluated for each variant.Results: Based on the results, the charge variants of the proposed biosimilar had no significant influence on the examined efficacy and PK parameters.Conclusion: During the development and production of biosimilar mAbs, studying the effects of their charge variants on efficacy and PK parameters is needed. DOI: 10.52547/ibj.3837
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
[31]   Sulphonylurea Physicochemical-Pharmacokinetic Relationships in the Pancreas and Liver [J].
Fanning, Kent J. ;
Anissimov, Yuri G. ;
Roberts, Michael S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (08) :2807-2821
[32]   A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab [J].
Waller, Cornelius F. ;
Vutikullird, Apinya ;
Lawrence, Tracey E. ;
Shaw, Andrew ;
Liu, Mark Shiyao ;
Baczkowski, Mark ;
Sharma, Rajiv ;
Barve, Abhijit ;
Goyal, Parag ;
Donnelly, Charles ;
Sengupta, Nilanjan ;
Pennella, Eduardo J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (10) :2336-2343
[33]   Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer [J].
Yamamoto, Harukaze ;
Ando, Masashi ;
Aogi, Kenjiro ;
Iwata, Hiroji ;
Tamura, Kenji ;
Yonemori, Kan ;
Shimizu, Chikako ;
Hara, Fumikata ;
Takabatake, Daisuke ;
Hattori, Masaya ;
Asakawa, Takashi ;
Fujiwara, Yasuhiro .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) :12-18
[34]   A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects [J].
Pivot, Xavier ;
Curtit, Elsa ;
Lee, Yoon Jung ;
Golor, George ;
Gauliard, Anke ;
Shin, Donghoon ;
Kim, Youngdoe ;
Kim, Hansook ;
Fuhr, Rainard .
CLINICAL THERAPEUTICS, 2016, 38 (07) :1665-1673
[35]   Prediction of Vitreal Half-Life Based on Drug Physicochemical Properties: Quantitative Structure–Pharmacokinetic Relationships (QSPKR) [J].
Chandrasekar Durairaj ;
Jaymin C. Shah ;
Shruti Senapati ;
Uday B. Kompella .
Pharmaceutical Research, 2009, 26
[36]   Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury [J].
Waggoner, Lauren E. ;
Madias, Marianne I. ;
Hurtado, Alan A. ;
Kwon, Ester J. .
AAPS JOURNAL, 2021, 23 (05)
[37]   Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury [J].
Lauren E. Waggoner ;
Marianne I. Madias ;
Alan A. Hurtado ;
Ester J. Kwon .
The AAPS Journal, 23
[38]   Biochemical and pharmacokinetic characterisation of two PEGylated variants of dipetarudin [J].
Lopez, Mercedes ;
Koehler, Anne ;
Nowak, Goetz .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (03) :454-459
[39]   Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer [J].
Satoh, Taroh ;
Omuro, Yasushi ;
Sasaki, Yasutsuna ;
Hamamoto, Yasuo ;
Boku, Narikazu ;
Tamura, Takao ;
Ohtsu, Atsushi .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) :949-955
[40]   Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer [J].
Taroh Satoh ;
Yasushi Omuro ;
Yasutsuna Sasaki ;
Yasuo Hamamoto ;
Narikazu Boku ;
Takao Tamura ;
Atsushi Ohtsu .
Cancer Chemotherapy and Pharmacology, 2012, 69 :949-955